StockData
Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX) stock

EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$6.62−0.72 (-9.81%)

Close on Nov 17, 2026Market cap $399.15MP/E –Yield –

Eupraxia Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Eupraxia Pharmaceuticals's price to book ratio was 5.1× on Nov 11, 2026, against 6.6× a year earlier. Over the last 4 years it ranged from 3.5× to 61.7×, with a median of 8.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.1×−3.0
2025Dec 31, 20258.1×−31.0
2024Dec 31, 202439.0×+27.5
2023Dec 29, 202311.5×–

More Eupraxia Pharmaceuticals figures

See a number that looks wrong?